Details for New Drug Application (NDA): 207310
✉ Email this page to a colleague
The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 207310
Tradename: | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
Applicant: | Fresenius Kabi Usa |
Ingredient: | sodium chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 207310
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 207310
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 207310 | ANDA | Becton Dickinson and Company | 17271-701 | 17271-701-02 | 50 mL in 1 BAG (17271-701-02) |
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 207310 | ANDA | Becton Dickinson and Company | 17271-701 | 17271-701-03 | 100 mL in 1 BAG (17271-701-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 900MG/100ML | ||||
Approval Date: | Sep 19, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription